Trepipam
![]() | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem (CID) | 5024 |
| ChemSpider | 4849 |
| Chemical and physical data | |
| Formula | C19H23NO2 |
| Molar mass | 297.39 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
Trepipam (INN) is a dopamine receptor agonist of the benzazepine group that was never marketed.[1]
References
- ↑ Daniel Lednicer (4 March 2009). Strategies for Organic Drug Synthesis and Design. John Wiley & Sons. pp. 495–. ISBN 978-0-470-39959-0.
This article is issued from Wikipedia - version of the 11/23/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
